Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers

INTRODUCTION: Blood‐based Alzheimer's disease (AD) biomarkers show promise, but pre‐analytical protocol differences may pose problems. We examined seven AD blood biomarkers (amyloid beta [[Formula: see text] , [Formula: see text] , [Formula: see text] , total tau [t‐tau], neurofilament light ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonaitis, Erin M., Zetterberg, Henrik, Koscik, Rebecca Langhough, Betthauser, Tobey J., Van Hulle, Carol A., Hogan, Kirk, Hegge, Laura, Kollmorgen, Gwendlyn, Suridjan, Ivonne, Gleason, Carey E., Engelman, Corinne D., Okonkwo, Ozioma C., Asthana, Sanjay, Bendlin, Barbara B., Carlsson, Cynthia M., Johnson, Sterling C., Blennow, Kaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Blood‐based Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828996/
https://www.ncbi.nlm.nih.gov/pubmed/35155728
http://dx.doi.org/10.1002/dad2.12266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828996/
https://www.ncbi.nlm.nih.gov/pubmed/35155728
http://dx.doi.org/10.1002/dad2.12266

Ejemplares similares